Homo-BacPROTAC7 TFA
Based on 1 Customer Validation
Homo-BacPROTAC7 TFA is a PROTAC protein degrader targeting ClpC1/ClpC2 with a Kd of 0.5-2.5 nM for both targets. Homo-BacPROTAC7 (TFA) acts as a bactericidal agent, induces killing of pathogenic mycobacteria, retains activity against dormant-like mycobacterial cells with reduced intracellular ATP levels, and shows elevated antibiotic potency relative to its parent monomer. Homo-BacPROTAC7 (TFA) can be used for the research of tuberculosis.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 98.93%
- Fòrmula: C111H150F12N22O26
- Peso molecular:2436.49
-
Almacenamiento:
-20°C, protect from light, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
Ver todos los productos específicos de isoformas PROTACs
More
Actividad biológica
Descripciòn
In Vitro
Homo-BacPROTAC7 TFA (100 μM; 2 h) induces degradation of ~80% of purified M. tuberculosis ClpC1_NTD substrate via the ClpC1P1P2 protease in vitro[1].
Homo-BacPROTAC7 TFA (12.5 μM; 24 h) reduces ClpC1 levels to 34% and ClpC2 levels to 51% (relative to dCym7 treatment) in M. smegmatis ATCC 607 cells[1].
Homo-BacPROTAC7 TFA (100-0.048 μM; 5 days) exhibits potent antibacterial activity against M. tuberculosis H37Rv wild-type cells with an MIC50 of 0.26 μM (150-fold more potent than dCymM) and against ΔclpC2 mutant cells with an MIC50 of 0.18 μM after 5 days of treatment[1].
Homo-BacPROTAC7 TFA(7.8 μM; 48 h) induces a 5-fold reduction in ClpC1 levels and significant reduction in ClpC2 levels in M. tuberculosis H37Rv wild-type cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Appearance Solid
-
Peso molecular 2436.49
-
Fòrmula C111H150F12N22O26
-
Color White to off-white
-
SMILES
O=C(N[C@H](C(N(C)[C@H](C(N[C@@H](CC1=CN(CCCCCN2N=NC(C[C@H](NC([C@@H](N(C)C([C@H](C(C)C)NC([C@H]([C@@H](C3=CC=CC=C3)OC)NC([C@H](C)NC([C@@H](N4C)C[C@@H](C)CO)=O)=O)=O)=O)CC(C)C)=O)C(N[C@@H](CC5=CN(C)C6=C5C=CC=C6)C4=O)=O)=C2)N=N1)C(N[C@@H](CC7=CN(C)C8=C7C=CC=C8)C9=O)=O)=O)CC(C)C)=O)C(C)C)[C@@H](NC([C@H](C)NC([C@H](C[C@H](CO)C)N9C)=O)=O)[C@H](OC)C%10=CC=CC=C%10.FC(F)(F)C(O)=O.FC(F)(F)C(O)=O.FC(F)(F)C(O)=O.FC(F)(F)C(O)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
-20°C, protect from light, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
Solvente y solubilidad
In Vitro:
DMSO : 100 mg/mL (41.04 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (1.03 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Pureza y Documentación
-
Ficha de datos (284 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
Hot Topics
-
All
-
Topics
-
Most Recent
-
Oldest
-
Topics Targeted Protein Degradation (TPD): From PROTACs to Molecular Glues
Targeted protein degradation is a drug discovery strategy that uses cellular protein degradation systems to selectively eliminate disease-associated proteins, and its core modalities include PROTACs and molecular glue degraders.
2026-06-18
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 0.4104 mL | 2.0521 mL | 4.1043 mL | 10.2607 mL |
| 5 mM | 0.0821 mL | 0.4104 mL | 0.8209 mL | 2.0521 mL | |
| 10 mM | 0.0410 mL | 0.2052 mL | 0.4104 mL | 1.0261 mL | |
| 15 mM | 0.0274 mL | 0.1368 mL | 0.2736 mL | 0.6840 mL | |
| 20 mM | 0.0205 mL | 0.1026 mL | 0.2052 mL | 0.5130 mL | |
| 25 mM | 0.0164 mL | 0.0821 mL | 0.1642 mL | 0.4104 mL | |
| 30 mM | 0.0137 mL | 0.0684 mL | 0.1368 mL | 0.3420 mL | |
| 40 mM | 0.0103 mL | 0.0513 mL | 0.1026 mL | 0.2565 mL |